LOGIN  |  REGISTER
Recursion
C4 Therapeutics

Brookdale Senior Living Reports June 2023 Occupancy

July 11, 2023 | Last Trade: US$6.73 0.15 -2.18

NASHVILLE, Tenn., July 11, 2023 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) reported today its consolidated occupancy for June 2023.

Brookdale’s Consolidated Occupancy

June 2023 Observations:

  • June weighted average occupancy increased 160 basis points year-over-year, from 75.2% in 2022 to 76.8% in 2023. This represented a 20 basis point sequential increase compared to May 2023.
  • Achieved twenty consecutive months of year-over-year weighted average occupancy growth.
  • Weighted average occupancy increased sequentially each month within the quarter and the second quarter weighted average occupancy of 76.5% represented 190 basis points of year-over-year growth and 20 basis points of sequential growth compared to the first quarter 2023.

About Brookdale Senior Living

Brookdale Senior Living Inc. is the nation's premier operator of senior living communities. The Company is committed to its mission of enriching the lives of the people it serves with compassion, respect, excellence, and integrity. The Company, through its affiliates, operates independent living, assisted living, memory care, and continuing care retirement communities. Through its comprehensive network, Brookdale helps to provide seniors with care and services in an environment that feels like home. The Company's expertise in healthcare, hospitality, and real estate provides residents with opportunities to improve wellness, pursue passions, and stay connected with friends and loved ones. Brookdale, through its affiliates, operates and manages 672 communities in 41 states as of June 30, 2023, with the ability to serve more than 60,000 residents. Brookdale's stock trades on the New York Stock Exchange under the ticker symbol BKD. For more information, visit brookdale.com or connect with Brookdale on Facebook or Twitter.

 

Astria Therapeutics

Stock Quote

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB